Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 8,021,054,400
  • Market Capitalization, $K 8,021,054
  • Shares Outstanding, K 73,500
  • 36-Month Beta 1.38
  • Price/Book N/A
  • Price/Earnings ttm 19.73
  • Annual Dividend & Yield 0.19 (0.17%)
  • Most Recent Dividend 0.032 on 09/26/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
106.02 +4.42%
on 01/30/19
112.59 -1.67%
on 02/19/19
+1.99 (+1.83%)
since 01/22/19
3-Month
89.01 +24.38%
on 12/24/18
112.59 -1.67%
on 02/19/19
+7.91 (+7.69%)
since 11/21/18
52-Week
89.01 +24.38%
on 12/24/18
122.97 -9.97%
on 10/01/18
+2.29 (+2.11%)
since 02/22/18

Most Recent Stories

More News
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.34 (+1.47%)
IBB : 110.71 (+1.43%)
VRTX : 185.76 (+1.47%)
QGEN : 39.04 (+0.67%)
REGN : 422.52 (+0.93%)
XBI : 85.74 (+1.96%)
Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

IBB : 110.71 (+1.43%)
FBT : 144.92 (+1.62%)
BBH : 128.10 (+1.64%)
GILD : 65.74 (+0.29%)
AMGN : 187.50 (+1.08%)
BIIB : 325.33 (+1.30%)
ALXN : 129.73 (+1.71%)
Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings

Biotech stocks came up with mixed earnings and weighed on the related ETFs in the key reporting season.

IBB : 110.71 (+1.43%)
FBT : 144.92 (+1.62%)
BBH : 128.10 (+1.64%)
GILD : 65.74 (+0.29%)
AMGN : 187.50 (+1.08%)
BIIB : 325.33 (+1.30%)
ALXN : 129.73 (+1.71%)
What's Behind the Biotech ETF Rally to Start 2019?

Biotech ETFs have been riding on the wave of mergers and acquisitions as well as drug approvals.

IBB : 110.71 (+1.43%)
IVV : 280.82 (+0.58%)
BBH : 128.10 (+1.64%)
ABBV : 80.02 (+1.61%)
BMY : 50.98 (+1.70%)
BTEC : 33.24 (+1.25%)
BBP : 41.48 (+1.80%)
AZN : 40.94 (+1.26%)
LLY : 124.00 (+1.04%)
FBT : 144.92 (+1.62%)
CLVS : 25.32 (+4.71%)
GILD : 65.74 (+0.29%)
GSK : 40.55 (+0.02%)
BIIB : 325.33 (+1.30%)
What's Behind the Biotech ETF Rally to Start 2019?

Biotech ETFs have been riding on the wave of mergers and acquisitions as well as drug approvals.

IBB : 110.71 (+1.43%)
IVV : 280.82 (+0.58%)
BBH : 128.10 (+1.64%)
ABBV : 80.02 (+1.61%)
BMY : 50.98 (+1.70%)
BTEC : 33.24 (+1.25%)
BBP : 41.48 (+1.80%)
AZN : 40.94 (+1.26%)
LLY : 124.00 (+1.04%)
FBT : 144.92 (+1.62%)
CLVS : 25.32 (+4.71%)
GILD : 65.74 (+0.29%)
GSK : 40.55 (+0.02%)
BIIB : 325.33 (+1.30%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 89.14 (+0.55%)
BLUE : 131.32 (+3.21%)
IHE : 151.88 (+1.68%)
PJP : 66.36 (+0.85%)
IBB : 110.71 (+1.43%)
BBH : 128.10 (+1.64%)
IEIH : 25.82 (+1.25%)
BMY : 50.98 (+1.70%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.34 (+1.47%)
IBB : 110.71 (+1.43%)
QGEN : 39.04 (+0.67%)
GILD : 65.74 (+0.29%)
REGN : 422.52 (+0.93%)
XBI : 85.74 (+1.96%)
Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus

The news has put the spotlight on a number of healthcare ETFs, especially biotech and pharma, which could be the best ways for investors to tap the opportunity arising from the BMY-CELG deal.

CELG : 89.14 (+0.55%)
BLUE : 131.32 (+3.21%)
IHE : 151.88 (+1.68%)
PJP : 66.36 (+0.85%)
IBB : 110.71 (+1.43%)
BBH : 128.10 (+1.64%)
IEIH : 25.82 (+1.25%)
BMY : 50.98 (+1.70%)
Mirati Therapeutics Added To NASDAQ Biotechnology Index

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq: ^NBI). The Company's...

IBB : 110.71 (+1.43%)
MRTX : 76.01 (+0.62%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.34 (+1.47%)
ILMN : 301.06 (+1.41%)
IBB : 110.71 (+1.43%)
VRTX : 185.76 (+1.47%)
AMGN : 187.50 (+1.08%)
XBI : 85.74 (+1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 112.02
1st Resistance Point 111.37
Last Price 110.71
1st Support Level 109.58
2nd Support Level 108.44

See More

52-Week High 122.97
Last Price 110.71
Fibonacci 61.8% 110.00
Fibonacci 50% 105.99
Fibonacci 38.2% 101.98
52-Week Low 89.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar